Barish Edil to Antineoplastic Agents
This is a "connection" page, showing publications Barish Edil has written about Antineoplastic Agents.
Connection Strength
0.506
-
Neuroendocrine pancreatic tumors: guidelines for management and update. Curr Treat Options Oncol. 2012 Mar; 13(1):24-34.
Score: 0.263
-
Pomalidomide Inhibits PD-L1 Induction to Promote Antitumor Immunity. Cancer Res. 2018 12 01; 78(23):6655-6665.
Score: 0.104
-
Phase 2 study of erlotinib combined with adjuvant chemoradiation and chemotherapy in patients with resectable pancreatic cancer. Int J Radiat Oncol Biol Phys. 2013 Jul 15; 86(4):678-85.
Score: 0.072
-
Treating patients with colon cancer liver metastasis: a nationwide analysis of therapeutic decision making. Ann Surg Oncol. 2012 Nov; 19(12):3668-76.
Score: 0.068